Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems

Core Insights - Daxor Corporation is expanding its blood volume measurement technology into East Tennessee and the Pacific Northwest, enhancing care for cardiovascular and critical care patients [1][2] - The company utilizes dual implementation models, including concierge laboratory services and on-site systems, to meet diverse clinical needs [2] - Daxor's proprietary technology, including the BVA-100® analyzer, is FDA-cleared and has been shown to reduce mortality, hospital readmissions, and length of stay for heart failure patients [3][5] Company Overview - Daxor Corporation is recognized as the global leader in blood volume measurement technology, with over 70,000 tests performed in leading U.S. hospitals [3] - The company is involved in ongoing clinical trials for heart failure treatment, supported by the NIH, and is developing analyzers for combat casualty care with the U.S. Department of Defense [3] Recent Developments - A premier regional referral center in East Tennessee has integrated Daxor's ezBVA Lab service into its cardiology practice, providing diagnostic results within 24 hours [5] - A leading healthcare facility in the Pacific Northwest has implemented Daxor's on-site BVA analyzer system, facilitating immediate access to critical blood volume data for clinical decision-making [5]